METFORMIN TREATMENT IN NONDIABETIC HIV-INFECTED INDIVIDUALS ON ART
The mechanistic target of rapamycin (mTOR) promotes HIV transcription. In line, we demonstrated that HIV preferentially targets gut-homing CCR6+Th17 cells for replication/persistence via mTOR-dependent mechanisms. Thus, mTOR inhibitors may limit residual HIV transcription during ART and subsequently reduce immune activation/inflammation. Here, we report results from a clinical trial conceived to evaluate the effect of 12…